公司简介
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, including Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provi...
关联新闻
- Here's How Much Traders See Eli Lilly Stock Moving After Earnings
Eli Lilly is scheduled to report earnings Wednesday morning, with traders expecting the drugmaker's stock could potentially approach last month's highs following the results.
- JPMorgan names 3 stocks worth buying ahead of August earnings
US stock market is entering August against a turbulent backdrop, featuring continued Iran-driven volatility in oil prices and an ongoing earnings season. Plus, investors are still processing the recen...
- Eli Lilly to offer early access to next-gen obesity drug to some patients
Eli Lilly said on Monday it would allow a limited number of patients to have early access to its experimental obesity drug, retatrutide, before its U.S. FDA approval.